Clinical trials
Terminated Brain Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
280 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 6 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 7 |
| 2005 | 7 |
| 2006 | 11 |
| 2007 | 10 |
| 2008 | 17 |
| 2009 | 16 |
| 2010 | 16 |
| 2011 | 16 |
| 2012 | 14 |
| 2013 | 13 |
| 2014 | 14 |
| 2015 | 15 |
| 2016 | 15 |
| 2017 | 15 |
| 2018 | 11 |
| 2019 | 15 |
| 2020 | 8 |
| 2021 | 13 |
| 2022 | 10 |
| 2023 | 9 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 280 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 23 |
| M.D. Anderson Cancer Center | 16 |
| Case Comprehensive Cancer Center | 7 |
| Duke University | 7 |
| H. Lee Moffitt Cancer Center and Research Institute | 6 |
| University of Florida | 5 |
| Vanderbilt-Ingram Cancer Center | 5 |
| Indiana University | 4 |
| OHSU Knight Cancer Institute | 4 |
| University of Utah | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 280 |
| Glioblastoma | 79 |
| Glioma | 56 |
| Astrocytoma | 36 |
| Gliosarcoma | 32 |
| Melanoma | 30 |
| Neoplasm Metastasis | 29 |
| Oligodendroglioma | 24 |
| Lung Neoplasms | 23 |
| Breast Neoplasms | 22 |
Trials
Showing 76 to 100 of 280. Each trial links to its page on Pharma Observatory.
180 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.